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INTRODUCTION:  A phyllodes  tumor  is  a neoplasm  of  mixed  mesenchymal  and  epithelial  origin  affecting
the  breast.  It  may  pursue  a benign  or  malignant  evolution  with  distant  metastases  in the  latter  case.
Sites  most  commonly  affected  by metastases  are  the  lungs  and  bones.  Simple  mastectomy  is the  main-
stay  of  treatment.  This  article  presents  the  ﬁrst  described  case  of  metastasis  to  the adrenal  gland  after
sarcomatous  transformation  of  a phyllodes  tumor.  A review  of  the  literature  is presented  afterwards.
PRESENTATION OF  CASE:  A 57-year  old  female  patient  presented  with  a voluminous  breast  mass  which
was  completely  resected.  Unfortunately  she  presented  with  malignant  recurrence  in the  breast  which
was  also  resected.  A  later  recurrence  within  the  lung  presented  and  was  completely  resected  but showed
aspects  of  sarcomatous  changes.  Finally  a recurrence  was  pathologically  documented  within  the  adrenal
gland.  Unfortunately,  disease  later  progressed  and  the patient  refused  further  treatment  at  that  point.
DISCUSSION: While  malignant  transformation  of  breast  phyllodes  tumors  and  metastasis  is  relatively
common,  the  prognosis  for initially  benign  lesion  that  are  completely  excised  is  usually  good.  This  case
represents  the ﬁrst documented  metastasis  to  the adrenal  gland  of  a breast  phyllodes  tumor.
CONCLUSION: We  presented  the  ﬁrst case  of adrenal  metastasis  of a phyllodes  tumor  after  sarcomatous
degeneration.  This  is an  unusual  presentation  of  a relatively  uncommon  but  well-recognized  disease  of
variable  malignant  potential.
gical © 2013 Sur
. Introduction
Phyllodes tumors of the breast are relatively uncommon. They
riginate from both mesenchymal and epithelial cells of the breast
issue.1 The majority of these tumors are benign but some show
alignant potential and tend to metastasize. Recurrences may
appen and tend to be increasing in aggressiveness until a frank sar-
oma is present. The commonest sites of metastases are the lungs
nd bones, but other sites have also been described.2 We  present
he case of a patient with recurrent phyllodes tumor with adrenal
land metastasis. To the authors’ knowledge, this is the ﬁrst case
escribed in the literature.
Abbreviation: CT, Computerized tomodensitometry.
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2. Case report
A  57-year old female patient presented in early 2001 with a large
(20 cm)  tumor of the left breast. She was not known for any genetic
syndrome and had received a bilateral salpingo-ovariectomy and
hysterectomy for benign disease in the past. A biopsy of the breast
mass revealed a low-grade phyllodes tumor. The patient had a large
breast (cup size DD) so a breast-conserving surgery was  performed.
The pathology report conﬁrmed the presence of a 23 cm × 18 cm
low-grade benign phyllodes tumor.
One year later, the patient presented two new lesions in the left
breast. A core-needle biopsy conﬁrmed the recurrence of phyllodes
tumor. A total mastectomy was  then performed, with negative
macroscopic margins. At pathology, three lesions were identiﬁed,
two of high-grade morphology and one of intermediate grade. Fig. 1
shows an increase in cellularity, pleomorphism and mitoses, all
suggesting a malignant disease. Margins were clear of disease and
Open access under CC BY-NC-ND license. there was no lympho-vascular invasion. Histopathologic assess-
ment of two  nodes yielded negative results.
After 5 years of uneventful evolution, the patient started to
present shortness of breath. A chest X-ray was performed and a
NC-ND license. 
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Fig. 1. High power ﬁeld of the modiﬁed radical mastectomy. Histology shows
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iypercellularity,  pleomorphism, and cellular condensation around the epithelial
tructures with numerous mitoses. A diagnosis of malignant phyllodes tumor was
stablished.
ew nodule was present on the right lung. A thoraco-abdominal CT
can showed the presence of a 16 mm nodule in the apical segment
f the right lower lobe, and no other suspicious lesion. A PET-scan
onﬁrmed the presence of this lesion with no other suspicious
esion. A trans-thoracic biopsy of the nodule revealed mesenchymal
umor of unknown origin with marked pleomorphism and frequent
itoses. The patient was then operated for a right superior and
iddle bilobectomy. Pathology reported a sarcomatous tumor with
landular structures surrounded by fusiform cells with increased
leomorphism, atypia and many mitoses (more than 10 per high
ower ﬁeld). Immunohistochemistry showed positivity for CD10
nd vimentine. Pathology was compatible with metastasis originat-
ng from the initial breast phyllodes tumor. The bronchial margins
ere at least 3 cm but there was invasion of the visceral pleura.
One year later, the patient presented weight loss and fatigue.
 CT-scan showed two new lesions: a left adrenal tumor measur-
ng 8.2 cm × 9.3 cm with heterogeneous composition (Fig. 2) and
Fig. 2. Abdominal CT scan showing heterogeneous left adrenal mass.Fig. 3. Histology of the adrenal tumor shows hypercellular mesenchymal prolifer-
ation.  Comparison with the lung tumor histology suggested another metastasis of
the phyllodes tumor.
a 3.4 cm × 3.6 cm pelvic tumor of the same radiologic appearance
as the adrenal tumor. There was  a plane between the adrenal
and the left kidney. The PET scan revealed moderate hyperactiv-
ity in the adrenal lesion and no activity in the pelvic lesion. The
patient underwent left adrenalectomy and the pathology report
showed hypercellular mesenchymal proliferation with marked
nuclear pleomorphism and numerous mitoses without glandular
proliferation (Fig. 3). After comparison, the adrenal tumor displayed
the same histologic pattern as the lung tumor. Hence, pathologic
analysis suggested an high-grade adrenal metastasis of a phyllodes
tumor of the breast, with an intact capsule. During the same opera-
tion, it was  found that the pelvic tumor was in fact retro-rectal and
was ﬁxed. A biopsy of the mass revealed a carcinomatous architec-
ture (glandular). Immunohistochemistry on the retro-rectal tumor
showed positivity for cytokeratin 7, negativity for CD10, and diffuse
positivity for estrogen receptors, suggesting a gynecologic origin.
A diagnosis of retro-rectal clear-cell adenocarcinoma was  estab-
lished, and it was clear that this tumor was  totally different from
the adrenal tumor.
A  consultation in medical genetics yielded no conclusion with
regards to the etiology of this patient’s disease. Her case was
presented at multiple tumor boards and she received ﬁve cycles
of systemic chemotherapy (gemcitabine and docetaxel) for the
retro-rectal clear cell adenocarcinoma with complete response
conﬁrmed by PET scan in March 2009.
A few months later, the patient complained of generalized
fatigue. An abdominal ultrasound revealed a 22 cm mass in the
region of the left adrenal area pushing and possibly involving the
left kidney. A new PET-CT in August 2009 revealed hypermetabolic
lesions in the left adrenal region, in both lungs, and possible diffuse
bone marrow invasion. The patient refused further investigation
and treatment and opted for palliative care. She unfortunately died
about 8 months later, so around 9 years after the initial diagnosis.
3.  Discussion
Phyllodes tumors of the breast (cystosarcoma phyllodes) are
relatively uncommon but well-recognized tumors. They represent
less than 1% of all breast tumors and they occur mostly in women
aged 35–55 of Latin or East Asian descent.3 They can be caused
by genetic syndromes, notably Li–Fraumeni syndrome, which is
related to breast cancers, brain tumors, soft tissue sarcomas, bone
sarcomas and rarely other types of tumors. Histologically, phyl-
lodes tumors are described as a mixed epithelial and mesenchymal
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umor with the mesenchymal aspect usually being the only malig-
ant one. Most phyllodes tumors are benign and do not metastasize,
ut recurrence rates are not negligible. In around 10–20% of all
hyllodes tumors, a malignant potential is identiﬁed, with recur-
ence rates quite high (30–40%). Metastases may  occur in 25–40%
f cases.4 When metastasis does occur, it happens on average 2
ears after the initial diagnosis.5 The most common sites of distant
etastasis are lungs and bones. Some cases of metastases to the
ediastinum or central nervous system have been reported, but
one for adrenal metastasis.6
Interestingly, recurrent phyllodes tumors are known to be
ore aggressive, with a higher rate of another recurrence or
etastasis. This seemed to be the case with our patient. Diag-
osis may  be suggested by mammography (large well deﬁned
val or lobulated tumor with coarse microcalciﬁcations) or by
reast ultrasound (heterogeneous, solid mass sometimes associ-
ted with cystic components) but unfortunately, an out of doubt
istinction with ﬁbroadenoma is not possible. Excisional biopsy is
hus required since diagnosis is based on histopathological ele-
ents and architecture. Also, immuno-histological pathological
ssays represent important ancillary techniques.7 For instance,
igniﬁcant markers related to the malignant potential of the
umor are Ki67, CD10, CD117 and p53. Vimentin is expressed
y the mesenchymal component whereas cytokeratines, nor-
ally associated with epithelial tumors, are usually absent in
he mesenchymal tissue of the tumor. It is expressed exclusively
n the epithelial component.7,8 The recommended treatment of
rimary phyllodes tumors, local recurrence and distant metasta-
is is surgery with clear margins. In fact, clear margins reduce
ecurrence by about 50% and seem to be the most important
rognostic factor.9,10 Another prognostic factor inﬂuencing recur-
ence and disease-free survival is the initial grade of the phyllodes
umor.11 Even if our patient underwent lymph node sampling
nd total mastectomy, the indication to perform lymph node dis-
ection has been studied, and as with other types of sarcomas,
oes not seem to provide any survival beneﬁt. In fact, phyllodes
umors do not seem to metastasize to lymph nodes. Radiother-
py is currently not recommended; neither are chemotherapy or
ormonotherapy.12,13
. Conclusion
Phyllodes tumors are rare tumors of mixed mesenchymal and
pithelial origin affecting the breast. Although they are most
ften benign, they can be malignant and metastasize. In cases
f metastases, the lungs and bones are the most common sites
ffected. To the authors’ knowledge, this is the ﬁrst case of
drenal metastasis of a phyllodes tumor of the breast. It brings new entity in the differential diagnosis of adrenal tumors. The
ase also shows that phyllodes tumors must be treated aggres-
ively since they do have a potential for high malignancy and
atality.
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